News & Events about Surmodics Inc.
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, will hold its Annual Meeting of Shareholders on Thursday, February 9, at 4 p.m. CT (5 p.m. ET), as a virtual meeting. Sue Knight, chair of the board, will lead the...
Surmodics, Inc. (Nasdaq: SRDX), a leading provider of medical device and in vitro diagnostic technologies to the healthcare industry, today announced that first quarter of fiscal year 2023 financial results will be released after the market closes on Monday, February 6. Management will host a live...
Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Jan. 24, 2023 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Surmodics, Inc (Surmodics or the Company) (NASDAQ: SRDX) investors that the firm has initiated an investigation into possible ...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surmodics, Inc. (Surmodics or the Company) (NASDAQ: SRDX) for violations of the securities laws. The investigation focuses on whether the Company issued false...
The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Surmodics, Inc. (Surmodics or the Company) (NASDAQ: SRDX) for violations of the securities laws. The investigation focuses on whether the Company issued false...